346 Clinical Effects of Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases

BACKGROUND: A humanized anti-interleukin-6 receptor, tocilizumab, has been approved as a biological drug for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis and Castleman's disease. Since dysregulation of IL-6 production also plays a pathologic role in other variou...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Tanaka, Toshio, Morishima, Atsuyoshi, Hishitani, Yoshihiro, Yoshida, Yuji, Nakabayashi, Akihiko, Ogawa, Masako, Kawai, Mari, Hirano, Toru, Hagihara, Keisuke, Shima, Yoshihito, Narazaki, Masashi, Ogata, Atsushi, Kishimoto, Tadamitsu, Kumanogoh, Atsushi
פורמט: Artigo
שפה:Inglês
יצא לאור: World Allergy Organization Journal 2012
נושאים:
Abstracts of the XXII World Allergy Congress
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513059/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000412109.80532.b7
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים